Skip to content

Towards a dynamic processual model of psychedelic microdosing.

Jason Hughes, Joshua Stuart-Bennett, Michael Dunning, Hannah Farrimond

International Journal of Drug Policy February 1, 2025 DOI: 10.1016/j.drugpo.2024.104691 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Qualitative study Peer reviewed
Sample size 23
Population Active, prospective, and past microdosers of psychedelics
Topics Microdosing
Keywords Phases Process sociology Psychedelics Temporalities
Citations 2
Key findings Microdosing pathways involve a series of phases—awareness, research, access, experimentation, incorporation, and expansion—that require ongoing work and can lead to greater temporal and relational expansiveness.

Abstract

Existing research highlights an increase in psychedelic microdosing, particularly for therapeutic purposes and as a means for self-enhancement. However, we know little about the different routes into and out of microdosing, particularly by those who do not consume other illicit substances, and of the processes involved in the development, maintenance, and cessation of practices. Drawing upon a trans-national interview-based study of 23 participants actively microdosing (n = 19), about to start (n = 3), or who were past users (n = 1), we develop a phased-based analysis of different user pathways. We identify key phases as: 'Awareness/Discovery', where participants became aware of microdosing; 'Research/Reframing', where they researched access, techniques, and undertook 'stigma work' to reframe risks; 'Access/Supply' where they sought reliable and safe sources of psychedelics and cultivated attitudes/practices/substances for longer-term use; 'Experimentation/Differentiation' where participants altered dosing levels/schedules and, inter-relatedly, differentiated 'effects' and 'benefits'; 'Independence/Incorporation' where they stabilised practices into patterns 'right for them'; and 'Expansion/Advocacy' where microdosing was linked to greater inter- and intrapersonal 'expansiveness'. Pathways in and out of microdosing are multilinear and differentiated. Nonetheless, a dynamic processual approach helps highlight the overall structure of changes involved which, we find, can entail a shift towards greater temporal and relational 'expansiveness', greater independence, and more incorporated practices. These shifts necessitated considerable 'work' variously to negate stigma, maintain supply, determine dose, document shifts, and other kinds of material-symbolic 'investment'. We also show the significance of processual/phased-based models beyond psychedelics to better understand drug-use journeys and temporalities which confound conventional dependency-focused paradigms.

Comparable studies

Other qualitative studies on microdosing, most cited first.

Study Year Design Participants
Psychedelic microdosing benefits and challenges: an empirical codebook Active microdosing community 2019 Mixed-methods study
Narrative identity, rationality, and microdosing classic psychedelics People who had microdosed classic psychedelics 2019 Qualitative study n = 30
Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTube YouTube videos and comments about psychedelic microdosing 2019 Qualitative study
Accounting for Microdosing Classic Psychedelics People who had microdosed classic psychedelics 2019 Qualitative study n = 30
Experiences of microdosing psychedelics in an attempt to support wellbeing and mental health. People who microdose psychedelic drugs 2023 Qualitative study n = 13

Citations in the library

Explore topics